Raia Drogasil S.A.
RADLY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $33,224 | $52,647 | $40,564 | $42,506 |
| - Cash | $528 | $412 | $434 | $356 |
| + Debt | $7,695 | $7,067 | $6,058 | $5,178 |
| Enterprise Value | $40,391 | $59,302 | $46,188 | $47,328 |
| Revenue | $38,864 | $33,974 | $29,067 | $24,127 |
| % Growth | 14.4% | 16.9% | 20.5% | – |
| Gross Profit | $11,550 | $10,207 | $8,809 | $7,206 |
| % Margin | 29.7% | 30% | 30.3% | 29.9% |
| EBITDA | $3,140 | $2,752 | $2,453 | $2,630 |
| % Margin | 8.1% | 8.1% | 8.4% | 10.9% |
| Net Income | $1,198 | $1,055 | $996 | $752 |
| % Margin | 3.1% | 3.1% | 3.4% | 3.1% |
| EPS Diluted | 0.72 | 0.62 | 0.58 | 0.44 |
| % Growth | 16.1% | 6.9% | 31.8% | – |
| Operating Cash Flow | $1,913 | $963 | $1,682 | $1,551 |
| Capital Expenditures | -$1,284 | -$1,305 | -$1,189 | -$856 |
| Free Cash Flow | $629 | -$342 | $493 | $695 |